New 13D34
New 13G51
Stated intents1
The week of 2025-08-18, 34 holders filed a new Schedule 13D and 51 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-08-22 | Healthy Extracts Inc. | Swanson Donald William | 77.5% | SCHEDULE 13D |
| 2025-08-20 | Ryojbaba Co., Ltd. | Ryoji Baba | 71.32% | SCHEDULE 13D |
| 2025-08-18 | Soho House & Co Inc. | Yucaipa American Alliance Fund Ii LP | 49.3% | SCHEDULE 13D |
| 2025-08-21 | Bullish | Brendan F. Blumer | 28.1% | SCHEDULE 13D |
| 2025-08-21 | Bullish | Kokuei Yuan | 24.9% | SCHEDULE 13D |
| 2025-08-21 | Zapata Quantum, Inc. | Clark Golestani | 22.6% | SCHEDULE 13D |
| 2025-08-21 | Zapata Quantum, Inc. | Sumit Kapur | 22.5% | SCHEDULE 13D |
| 2025-08-18 | Deep Isolation Nuclear, Inc. | Elizabeth Muller | 22.1% | SCHEDULE 13D |
| 2025-08-22 | Cantor Equity Partners IV, Inc. | Cantor EP Holdings IV, LLC | 21.3% | SCHEDULE 13D |
| 2025-08-20 | Superior Industries International Inc | SUP Parent Holdings, LLC | 20.4% | SCHEDULE 13D |
| 2025-08-18 | Starry Sea Acquisition Corp | STARRY SEA INVESTMENT Ltd | 18.83% | SCHEDULE 13D |
| 2025-08-18 | BridgeBio Oncology Therapeutics, Inc. | BridgeBio Pharma LLC | 17.5% | SCHEDULE 13D |
| 2025-08-20 | Smart Share Global Limited | Hillhouse Investment Management, Ltd. intent stated | 14.4% | SCHEDULE 13D |
| 2025-08-20 | Alkami Technology, Inc. | General Atlantic, L.P. | 11.6% | SCHEDULE 13D |
| 2025-08-21 | Miami International Holdings | Horizon Kinetics Asset Management LLC | 10.7% | SCHEDULE 13D |
| 2025-08-18 | Plymouth Industrial REIT, Inc. | Tssp Sub-Fund Holdco, LLC | 9.99% | SCHEDULE 13D |
| 2025-08-18 | X4 Pharmaceuticals, Inc. | Coastlands Capital LP | 9.99% | SCHEDULE 13D |
| 2025-08-19 | Regional Health Properties, Inc | Charles Frischer | 9.8% | SCHEDULE 13D |
| 2025-08-22 | Charles & Colvard Ltd | Pham Duc Hoang | 9.6% | SCHEDULE 13D |
| 2025-08-22 | Pintec Technology Holdings Limited | Jun Dong | 9.4% | SCHEDULE 13D |
| 2025-08-22 | Nedbank Group LTD | Standard Bank Of South Africa Ltd | 7.1% | SCHEDULE 13D |
| 2025-08-21 | Regional Health Properties, Inc | Robert M. Thornton, Jr. | 6.94% | SCHEDULE 13D |
| 2025-08-19 | Rapid Micro Biosystems, Inc. | Spignesi Robert G Jr | 6.3% | SCHEDULE 13D |
| 2025-08-19 | Core Scientific, Inc. | Situational Awareness LP | 5.8% | SCHEDULE 13D |
| 2025-08-20 | Edgemode, Inc. | Paul Taylor | 5.77% | SCHEDULE 13D |
| 2025-08-22 | Central Pacific Financial Corp | HoldCo Asset Management, LP | 5.7% | SCHEDULE 13D |
| 2025-08-20 | Ryojbaba Co., Ltd. | Satoshi Saito | 5.69% | SCHEDULE 13D |
| 2025-08-21 | Resources Connection, Inc. | Poplar Point Capital Management LLC | 5.6% | SCHEDULE 13D |
| 2025-08-18 | Innventure, Inc. | Otworth Michael | 5.5% | SCHEDULE 13D |
| 2025-08-19 | ACCESS Newswire Inc. | 2717 Partners LP | 5.5% | SCHEDULE 13D |
| 2025-08-21 | MacKenzie Realty Capital, Inc. | Dixon Robert E | 5.5% | SCHEDULE 13D |
| 2025-08-19 | Primis Financial Corp. | Patriot Financial Partners III, L.P. | 5.35% | SCHEDULE 13D |
| 2025-08-21 | ZoomInfo Technologies Inc. | HighSage Ventures LLC | 5.3% | SCHEDULE 13D |
| 2025-08-21 | Miami International Holdings | Thomas P. Gallagher | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-08-18 | Aspen Insurance Holdings Limited | Apollo Management Holdings GP, LLC | 82.1% | SCHEDULE 13G |
| 2025-08-19 | Renx Enterprises Corp. | Strategic EP, LLC | 22.5% | SCHEDULE 13G |
| 2025-08-19 | NextCure, Inc. | Simcere Zaiming, Inc. | 12.7% | SCHEDULE 13G |
| 2025-08-21 | NRX Pharmaceuticals, Inc. | The B Group, Inc. | 12.62% | SCHEDULE 13G |
| 2025-08-21 | eToro Group Ltd. | Andalusian Private Capital, LP | 11.26% | SCHEDULE 13G |
| 2025-08-19 | X4 Pharmaceuticals, Inc. | Deep Track Capital, LP | 9.99% | SCHEDULE 13G |
| 2025-08-20 | Azitra, Inc. | Alumni Capital LP | 9.99% | SCHEDULE 13G |
| 2025-08-19 | Odyssey Marine Exploration Inc | Greywolf Capital Management LP | 9.98% | SCHEDULE 13G |
| 2025-08-18 | X4 Pharmaceuticals, Inc. | Trails Edge Capital Partners, LP | 9.9% | SCHEDULE 13G |
| 2025-08-19 | Propanc Biopharma, Inc. | Ionic Ventures, LLC | 9.9% | SCHEDULE 13G |
| 2025-08-20 | X4 Pharmaceuticals, Inc. | Bvf Partners L P | 9.9% | SCHEDULE 13G |
| 2025-08-20 | Jet.AI Inc. | Hexstone Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-08-20 | VivoPower PLC | Ceres Digital Holdings Limited | 9.89% | SCHEDULE 13G |
| 2025-08-19 | Matinas BioPharma Holdings, Inc. | Lazar David E. | 9.81% | SCHEDULE 13G |
| 2025-08-18 | Bio Green Med Solution, Inc. | Kua Khai Loon | 9.8% | SCHEDULE 13G |
| 2025-08-18 | Bio Green Med Solution, Inc. | Ong Yee Lung | 9.8% | SCHEDULE 13G |
| 2025-08-18 | Bio Green Med Solution, Inc. | Yap Kim Choy | 9.8% | SCHEDULE 13G |
| 2025-08-18 | First Trust Exchange-Traded Fund VI | Win Advisors, Inc | 9.6% | SCHEDULE 13G |
| 2025-08-21 | ParaZero Technologies Ltd. | Brumder William George | 9.6% | SCHEDULE 13G |
| 2025-08-18 | Assembly Biosciences, Inc. | RA Capital Management, L.P. | 9.5% | SCHEDULE 13G |
| 2025-08-18 | McKinley Acquisition Corporation | Linden Capital L.P. | 9.3% | SCHEDULE 13G |
| 2025-08-20 | Powercompute, Inc. | Hexstone Capital LLC | 9.3% | SCHEDULE 13G |
| 2025-08-21 | GoPro, Inc. | Brumder William George | 8.5% | SCHEDULE 13G |
| 2025-08-21 | Envoy Medical, Inc. | Alta Partners LLC | 8.3% | SCHEDULE 13G |
| 2025-08-19 | AI Financial Corp | Jane Street Group, LLC | 8.2% | SCHEDULE 13G |
| 2025-08-19 | Red Robin Gourmet Burgers Inc | Bandera Partners LLC | 7.6% | SCHEDULE 13G |
| 2025-08-18 | Webull Corp | Jun Yuan | 7.4% | SCHEDULE 13G |
| 2025-08-21 | Liberty Broadband Corp | Css LLC | 6.83% | SCHEDULE 13G |
| 2025-08-20 | Crescent Biopharma, Inc. | 1Globe Capital LLC | 6.45% | SCHEDULE 13G |
| 2025-08-20 | Olo Inc. | Glazer Capital, LLC | 6.38% | SCHEDULE 13G |
| 2025-08-20 | Nasus Pharma Ltd. | Capital Point Ltd. | 6.35% | SCHEDULE 13G |
| 2025-08-18 | Evolus, Inc. | Timothy P. Lynch | 6.3% | SCHEDULE 13G |
| 2025-08-22 | Dave Inc. | Divisadero Street Capital Management, LP | 6.2% | SCHEDULE 13G |
| 2025-08-18 | BridgeBio Oncology Therapeutics, Inc. | Deerfield Management Company, L.P. | 6.17% | SCHEDULE 13G |
| 2025-08-21 | Zeta Network Group | Arena Investors, LP | 6.1% | SCHEDULE 13G |
| 2025-08-20 | Par Technology Corporation | Voss Capital, LP | 5.9% | SCHEDULE 13G |
| 2025-08-21 | CytomX Therapeutics, Inc. | Perceptive Advisors LLC | 5.9% | SCHEDULE 13G |
| 2025-08-22 | Aeva Technologies, Inc. | LG Innotek Co., Ltd. | 5.86% | SCHEDULE 13G |
| 2025-08-21 | Performant Healthcare, Inc. | Glazer Capital, LLC | 5.82% | SCHEDULE 13G |
| 2025-08-18 | Deep Isolation Nuclear, Inc. | Richard Muller | 5.8% | SCHEDULE 13G |
| 2025-08-20 | Goosehead Insurance, Inc. | Durable Capital Partners LP | 5.7% | SCHEDULE 13G |
| 2025-08-18 | Structure Therapeutics Inc | Bvf Partners L P | 5.6% | SCHEDULE 13G |
| 2025-08-19 | Scienture Holdings, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 5.55% | SCHEDULE 13G |
| 2025-08-18 | MasterBrand, Inc. | Coliseum Capital Management, LLC | 5.5% | SCHEDULE 13G |
| 2025-08-19 | Kodiak Sciences Inc | Point72 Asset Management, L.P. | 5.5% | SCHEDULE 13G |
| 2025-08-19 | Lyell Immunopharma, Inc. | Explore Investments LLC | 5.4% | SCHEDULE 13G |
| 2025-08-20 | HIVE Digital Technologies Ltd. | Citadel Securities GP LLC | 5.4% | SCHEDULE 13G |
| 2025-08-20 | Coreweave, Inc. | Jane Street Group, LLC | 5.4% | SCHEDULE 13G |
| 2025-08-20 | Uxin Ltd | Ruiting Holdings Limited | 5.2% | SCHEDULE 13G |
| 2025-08-19 | Above Food Ingredients Inc. | Arcadia Biosciences, Inc. | 5.08% | SCHEDULE 13G |
| 2025-08-18 | Syndax Pharmaceuticals Inc | Point72 Asset Management, L.P. | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-08-20 | Smart Share Global Limited | Hillhouse Investment Management, Ltd. intent stated | 14.4% | SCHEDULE 13D |
Download this data (CSV)86 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.